BioLife Solutions, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
BLFS Nasdaq 3840 www.biolifesolutions.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for BioLife Solutions, Inc.

BioLife Solutions (BLFS) Is Up 7.2% After Swinging From Loss To Q2 Profit - What's Changed - Aug 7th, 2026 2:13 am
BioLife Solutions, Inc. (BLFS) Q2 Earnings and Revenues Surpass Estimates - Aug 6th, 2026 3:40 pm
BioLife Solutions Reports Second Quarter 2026 Financial Results - Aug 6th, 2026 2:03 pm
Repligen (RGEN) Held An M&A Call With BioLife Solutions. - Jul 28th, 2026 2:12 pm
Repligen Reports Q2 Revenue Growth and Raises Full-Year 2026 Guidance - Jul 28th, 2026 8:05 am
Repligen to Expand Cell Therapy Capabilities With BioLife Buyout - Jul 23rd, 2026 9:36 am
Sector Update: Healthcare Stocks Softer Late Afternoon - Jul 22nd, 2026 1:48 pm
Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy Reach - Jul 22nd, 2026 1:03 pm
Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media - Jul 22nd, 2026 4:00 am
What Makes BioLife Solutions (BLFS) a Compelling Long-Term Hold? - Jun 18th, 2026 7:54 am
BioLife Solutions Leads 3 Stocks Estimated To Be Trading Below Fair Value - Jun 4th, 2026 5:38 am